Hongbo Chen
Kunming University of Science and Technology(CN)Zhejiang Chinese Medical University(CN)Union Hospital(CN)Guangxi University(CN)Longyan University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Kunming Medical University(CN)First People's Hospital of Yunnan Province(CN)First Affiliated Hospital of Kunming Medical University(CN)Peking University Third Hospital(CN)Beijing Haidian Hospital(CN)Kunming Municipal Hospital of Traditional Chinese Medicine(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, COVID-19 Clinical Research Studies, Osteoarthritis Treatment and Mechanisms, Nanoplatforms for cancer theranostics
Most-Cited Works
- → RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS(2016)598 cited
- → TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging(2018)448 cited
- → Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China(2020)426 cited
- → RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease(2017)368 cited
- → Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility(2013)317 cited
- → Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension(2020)306 cited